ArticleMacromolecular rapid communications2026
Photoresponsive Metallo-Supramolecular Systems Constructed From a Bidentate Ligand.
Article in Macromolecular rapid communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Metallosupramolecular polymers (MSPs) are stimuli-responsive materials whose properties can be tailored through the choice of ligand and metal salt. Their dynamic behavior is governed by the reversibility of the metal-ligand (ML) complexes and the ability to shift the equilibrium between assembled and disassembled states, enabling functions such as recyclability, healability, and adaptability. While heat is a simple and efficient stimulus, it makes temporal and spatial control difficult to achieve. To address this, we developed MSP systems composed of copolymers bearing 6-(1'-methylbenzimidazolyl)pyridine (MBP) ligands in varying concentrations, metal salts, and the photoacid generator (PAG) 2-(4-methoxystyryl)-4,6-bis(trichloromethyl)-1,3,5-triazine (MBTT). The MBP groups coordinate Fe(OTf)
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.